Hyperbaric oxygen preconditioning and the role of NADPH oxidase inhibition in postischemic acute kidney injury induced in spontaneously hypertensive rats by Kovacević, Sanjin et al.
RESEARCH ARTICLE
Hyperbaric oxygen preconditioning and the
role of NADPH oxidase inhibition in
postischemic acute kidney injury induced in
spontaneously hypertensive rats
Sanjin KovacevicID
1*, Milan Ivanov2, Zoran Miloradovic2, Predrag Brkic3, Una
Jovana VajicID
2, Maja Zivotic4, Nevena Mihailovic-StanojevicID
2, Djurdjica Jovovic2,
Danijela KaranovicID
2, Rada Jeremic3, Jelena Nesovic-OstojicID
1*
1 Department of Pathophysiology, Medical Faculty, University of Belgrade, Belgrade, Serbia, 2 Institute for
Medical Research, Department of Cardiovascular Physiology, University of Belgrade, Belgrade, Serbia,
3 Department of Medical Physiology, Medical Faculty, University of Belgrade, Belgrade, Serbia,
4 Department of Pathology, Medical Faculty, University of Belgrade, Belgrade, Serbia
* sanjin.kovacevic@med.bg.ac.rs (SK); jelena.nesovic-ostojic@med.bg.ac.rs (JNO)
Abstract
Renal ischemia/reperfusion injury is a common cause of acute kidney injury (AKI) and hyper-
tension might contribute to the increased incidence of AKI. The purpose of this study was to
investigate the effects of single and combined hyperbaric oxygen (HBO) preconditioning and
NADPH oxidase inhibition on oxidative stress, kidney function and structure in spontaneously
hypertensive rats (SHR) after renal ischemia reperfusion injury. HBO preconditioning was
performed by exposing to pure oxygen (2.026 bar) twice a day for two consecutive days for
60 minutes, and 24h before AKI induction. For AKI induction, the right kidney was removed
and ischemia was performed by clamping the left renal artery for 45 minutes. NADPH oxi-
dase inhibition was induced by apocynin (40 mg/kg b.m., intravenously) 5 minutes before
reperfusion. AKI significantly increased renal vascular resistance and reduced renal blood
flow, which were significantly improved after apocynin treatment. Also, HBO preconditioning,
with or without apocynin treatment showed improvement on renal hemodynamics. AKI signif-
icantly increased plasma creatinine, urea, phosphate levels and lipid peroxidation in plasma.
Remarkable improvement, with decrease in creatinine, urea and phosphate levels was
observed in all treated groups. HBO preconditioning, solitary or with apocynin treatment
decreased lipid peroxidation in plasma caused by AKI induction. Also, combined with apocy-
nin, it increased catalase activity and solitary, glutathione reductase enzyme activity in
erythrocytes. While AKI induction significantly increased plasma KIM– 1 levels, HBO precon-
ditioning, solitary or with apocynin decreased its levels. Considering renal morphology, signif-
icant morphological alterations present after AKI induction were significantly improved in all
treated groups with reduced tubular dilatation, tubular necrosis in the cortico-medullary zone
and PAS positive cast formation. Our results reveal that NADPH oxidase inhibition and
hyperbaric oxygen preconditioning, with or without NADPH oxidase inhibition may have ben-
eficial effects, but their protective role should be evaluated in further studies.
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Introduction
Acute kidney injury (AKI) is associated with significant in-hospital morbidity and mortality,
particularly in those admitted to the Intensive care units, where mortality rates may exceed
50% [1]. Besides increased mortality rates, there are chronic consequences that carry high risk
of developing or exacerbating chronic kidney disease and accelerated development of the end-
stage renal disease [2]. Several factors, such as hypertension [3], invasive diagnostic procedures
and complex surgery, especially cardiothoracic surgery, partial nephrectomy, renal transplan-
tation or renal stone surgery might contribute to the increased incidence of AKI [4].
Renal ischemia/reperfusion injury is a common cause of AKI [5–7]. The pathophysiology
of ischemic AKI is multifactorial and complex and includes increased oxidative stress, hemo-
dynamic alterations, inflammation, endothelial and epithelial injury, followed by reperfusion
injury [1]. A common link between AKI and hypertension is enhanced generation of reactive
oxygen species (ROS) during injury/disease progression, where NADPH oxidase, one of the
major ROS generators, has important role in both conditions [5]. Oxidative stress has a very
important role in renal damage, and opens potential targets for therapeutic intervention. It
both directly and indirectly affects all aspects of the kidney, including vascular reactivity, renal
hemodynamics, glomerular filtration, tubular reabsorption and secretion in all nephron seg-
ments [8].
Apocynin (APO, 4-hydroxy-3-methoxyacetophenone) is an efficient inhibitor of NADPH
oxidase. It shows antioxidant and anti-inflammatory effects and has been used in many experi-
mental models [9, 10]. Actually, precise mechanism of NADPH inhibition is still incompletely
defined, but involves the impairment of the intracellular translocation of two critical cytosolic
components of the NADPH-oxidase complex present in cell membrane. It also involves activa-
tion by myeloperoxidase, because the agents that promote release of this enzyme enhance effi-
cacy of apocynin, while inhibition is absent in cells devoid or deficient of myeloperoxidase
[10].
Hyperbaric oxygenation (HBO) has been used as a primary or adjunctive therapy over the
last 50 years. HBO is used to increase blood oxygen level that can penetrate to ischemic areas
and perilesioned tissue more deeply than under normobaric conditions and has found its
place, as primary or adjuvant therapy in the treatment protocols for different clinical condi-
tions [11–13]. Experimental studies and clinical observations support the evidence that HBO
preconditioning has beneficial effect in postischemic reperfusion injury [12–14]. It improves
oxygen delivery to an area with diminished circulation, resulting in improved endothelial
function and decreased local inflammation and edema. Also, it may directly affect gene expres-
sion, signal transduction and cell apoptosis [14]. It affects an antioxidant enzyme expression
and the time between two exposures can be observed as pseudohypoxia which is important for
upregulation of antioxidative enzymes. In traumatic brain injury, HBO attenuates inflamma-
tory responses by limiting production of inflammatory mediators, creating better environment
for repair and regeneration [12]. However, these effects are dependent on treatment parame-
ters–pressure and duration on the treatment [15, 16].
Up to date no effective treatment for AKI is available. Considering the complexity of of AKI
pathogenesis and the uprising prevalence of hypertension worldwide, it is reasonable to
assume that only combination of different treatment protocols could provide better prognosis
for recovery of postischemic AKI [17].
Taking all these things into consideration, the aim of this study was to evaluate the effects of
single and combined HBO preconditioning and NADPH oxidase inhibition on oxidative
stress, kidney function and structure in spontaneously hypertensive rats with postischemic
AKI.
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Material and methods
Ethics statement
The experimental protocol was approved by the Ethic Committee of the Institute for Medical
Research, University of Belgrade, Serbia (No. (No. 323-0702569/2018-05/2), according to the
National Law on Animal Welfare ("Službeni Glasnik" no. 41/09) that is consistent with guide-
lines for animal research and principles of the European Convention for the Protection of Ver-
tebrate Animals Used for Experimental and Other Purposes (Official Daily N. L 358/1-358/6,
18, December 1986) and Directive on the protection of animals used for scientific purposes
(Directive 2010/63/EU of the European Parliament and of the Council, 22.9.2010.).
Animals
Male spontaneously hypertensive rats (SHR, descendants of breeders originally obtained
through Taconic Farms, Germantown, NY, USA) 24 weeks old and about 300 g weight were
used in this study. The animals were bred at the Institute for Medical Research, University of
Belgrade, Serbia, and kept under controlled laboratory conditions (constant temperature
22 ± 1˚C, humidity of 65± 1%, 12 h light/dark cycle). The animals were housed in groups of
four rats per cage and fed with a standard chow for laboratory rats (Veterinarski zavod, Subo-
tica, Serbia) with free access to food and water. All experimental animals were monitored at
least once per day, including weekends and public holidays, throughout the course of the
study.
Experimental design
Hypertension was confirmed in all rats by indirect measurement on tail artery (Narco Bio Sys-
tems INC, Houston, TX, USA). The animals were randomly divided into five experimental
groups: sham-operated rats (SHAM, n = 9), rats with induced postischemic AKI (AKI, n = 11),
animals with AKI and apocynin treatment (AKI+APO, n = 11), group with HBO precondi-
tioning before AKI inducing (AKI+HBO, n = 14) and group with HBO preconditioning before
and apocynin treatment after AKI induction (AKI+APO+HBO, n = 13).
Animals with HBO preconditioning were placed into custom made experimental HBO
chamber (Holywell Neopren, Belgrade, Serbia) and exposed to 100% oxygen according to the
following protocol: 10 minutes of slow compression, 2.0 atmospheres absolute (ATA) for 60
minutes, and 10 minutes of slow decompression, twice a day, at 12 hours interval, during two
day period and 24 hours before AKI induction. Upon reaching the desired pressure, the flow
of oxygen was reduced to maintain constant pressure while allowing the flow out of the cham-
ber. This constant exchange accompanied by a tray of calcium carbonate crystals was used to
reduce the accumulation of CO2 in the chamber environment. This protocol corresponds to a
standard hyperbaric oxygen treatment that is routinely used in the clinical setting of Center
for Hyperbaric Medicine, Belgrade, Serbia [18], and is in a line with recommendations of The
Committee of the Undersea and Hyperbaric Medical Society [19]. Each exposure was started
at the same hour to exclude any confounding issues associated with the changes in biological
rhythm. Body temperature was not changed significantly after the HBOT. Rats were proceed-
ing to AKI induction 12 hours after the last HBO preconditioning.
All surgical procedures were performed in anaesthetized rats by injecting 35 mg/kg b.m.
sodium pentobarbital intraperitoneally. AKI was induced by removal of the right kidney and
atraumatic clamp occlusion of the left renal artery for 45 minutes. In sham-operated group
identical surgical procedure was performed, but without left renal artery clamping. NADPH
oxidase inhibitor, Apocynin (Sigma Aldrich, USA), was applied as a bolus injection 5 minutes
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before clamp removal, 40 mg/kg b.m., intravenously. Animals without apocynin treatment
received bolus of vehicle (saline, 50 μl, intravenously). At the end of AKI procedure, the
wound abdominal incision was satured and rats were placed into metabolic cages for 24 hours,
with free access to food and water. In order to alleviate postoperative pain, ketoprofen (5 mg/
kg b.m.) was administrated subcutaneously.
Hemodynamic measurements
All hemodynamic parameters were measured 24 hours after reperfusion. Measurement of sys-
temic hemodynamic parameters was conducted by a direct method, through a femoral artery
catheter (PE-50, Clay-Adams Parsippany, NY, USA), connected to a physiological data acqui-
sition system (9800TCR Cardiomax III-TCR, Columbus, OH, USA). A jugular vein was can-
nulated with PE-50 for the injection of cold saline. For the determination of cardiac output
(CO), the left carotid artery was catheterized with PE-50 tubing and attached to a thermo sen-
sor, which was coupled to the Cardiomax III. The other end of the thermocouple was placed in
cold saline. Following 20 min for stabilization after surgery, cold saline (0.2 ml) was supplied
through the jugular vein and mean arterial pressure (MAP), heart rate (HR), and CO were
recorded. Total peripheral vascular resistance (TPVR) was calculated from MAP and CO
(assuming that mean right arterial pressure is zero) and expressed as mmHg x min x kg/ml.
After abdominal incision and left renal artery preparation, renal blood flow (RBF) was
recorded by using T106 Small Animal Flowmeter (Transonic System Inc., Ithaca, NY, USA).
Renal vascular resistance (RVR) was calculated by dividing MAP with total blood flow through
the renal artery, normalized for the body weight and expressed as mmHg x min x kg/ml.
Sample collection
After hemodynamic measurements, blood samples, obtained by puncture of the abdominal
aorta were collected into tubes containing lithium-heparin (Li-heparin, Sigma-Aldrich, USA)
and used for further analysis. Blood was centrifuged to separate plasma from erythrocytes.
Until assaying, plasma samples were stored at -20˚C and erythrocytes samples at -80˚C. After
blood samples collection, animals were sacrificed by pentobarbital overdose injection. For
determination of morphological changes, kidney tissue was removed immediately after
sacrificing and then prepared for histological examination.
Biochemical analyses
Kidney function parameters, including plasma creatinine (PCr), urea (PU), phosphate
(PPhos), were measured using the automatic COBAS INTEGRA 400 plus (Hoffmann-La
Roche, Germany) analyser.
Measurement of oxidative stress parameters
Determination of lipid peroxidation. In order to determine the degree of lipid peroxida-
tion, the concentration of thiobarbituric acid reactive substances (TBARS) was measured in
plasma. TBARS assay was done by using 2-thiobarbituric acid (2,6-dihydrooxypyrimidine-
2-thiol; TBA, Acros, Organic), as previously described [20].
Determination of erythrocytes antioxidant enzyme activities. Antioxidant enzyme
activities of the erythrocytes, catalase (CAT), glutathione reductase (GR), superoxide dismut-
ase (SOD) and glutathione peroxidase (GSH-Px) were measured by spectrophotometry,
according to previously described methods [20].
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Determination of plasma kidney injury molecule—1 levels
Plasma kidney injury molecule– 1 (KIM-1) was determined by sandwich enzyme-linked
immunosorbent assay (ELISA) (R&D Systems, Inc). The detection range for KIM-1 was 7.8–
500 pg/ml.
Histological examination
For light microscopy observation, the renal tissue was fixed in 10% buffered formalin solution.
Later, the kidney was dehydrated in alcohol and embedded in paraffin block, cut into 5μm
thick sections and stained by hematoxiline eosine (HE) and periodic acid-Schiff (PAS) reagent.
Slides were examined by two independent pathologists blinded to the experimental protocol.
By light microscopy, according to the degree of lesions, following parameters were semi quan-
titatively evaluated: morphological alterations in renal tubular cells, on the scale from 0 to 4
(0 –normal tubular cells, 1 –loss of luminal membrane or brush borders, 2 –swelling and
vacuolization of cells, 3 –separation of the cells from tubular basal membrane, 4 –as previous
with complete loss of epithelial tubular cells); tubular dilatation and presence of intraluminal
PAS positive cast formations were graded same on scale from 0 to 3 (0 –without tubular dilata-
tion/PAS positive cast formations, 1 –up to 10%, 2 –up to 30%, 3 –more than 30% tubules
dilated/PAS positive cast present). The sum of these changes represented the histopathological
score for each group which was used for comparison between groups.
Statistical analysis
All data are expressed as the mean ± standard deviation (SD). A statistical analysis of each of
the parameters of interest was carried out using analysis Student’s t-test for independent sam-
ples and analysis of variance (One–way ANOVA). Animals in AKI group were compared to
SHAM operated rats using Student’s t-test for independent samples. P value<0.05 was consid-
ered significant. Animals in APO, HBO and APO+HBO group were compared to AKI using
One–way ANOVA. When a significant F value in One–way ANOVA test (p<0.05) was
obtained, post hoc test (Dunnett’s multiple comparisons test) was used. The statistical calcula-
tions were performed using GraphPad Prism for Windows (Version 7.0, GraphPad Software,
La Jolla California, USA).
Results
Hemodynamic parameters
Systemic hemodynamics values, 24 hours after reperfusion, are shown in Table 1. MAP was
significantly decreased in AKI group compared to SHAM group (p<0.001). Also, in AKI
group HR was significantly decreased in comparison to SHAM (p<0.05), without differences
in CO and TVPR. APO treatment significantly decreased TVPR (p<0.05), but without signifi-
cant impact on MAP, HR and CO vs. AKI. In groups with HBO preconditioning, with or with-
out APO treatment TVPR was significantly decreased compared to control AKI group, too
(p<0.05).
Considering renal hemodinamics, AKI significantly reduced RBF and increased RVR in
comparison to SHAM (RBF—p<0.001; RVR—p<0.001), while in APO group significant
improvement was found compared to AKI (RBF—p<0.001; RVR—p<0.001). HBO precondi-
tioning with (RBF—p<0.05; RVR—p<0.05) or without APO treatment (; RVR—p<0.05) also
showed improvement on renal hemodinamics in comparison to AKI (Fig 1A and 1B).
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Biochemical parameters
PCr, Pu, PPhos concentration are shown in Fig 2. AKI induction significantly increased total
PCr, Pu and PPhos levels when compared to SHAM group. Remarkable decrease in PCr levels
were observed in groups with APO treatment (p<0.001), HBO preconditioning and APO
treatment (p<0.001) and HBO preconditioning solitary (p<0.01, Fig 2A). Other two kidney
function parameters (PU, PPhos) in treated groups also showed significant improvement in
comparison to AKI control group (Fig 2B and 2C).
Oxidative stress parameters
Lipid peroxidation. Level of TBARS, as marker of lipid peroxidation, is shown in Fig 3.
In AKI group there was a significant increase (p<0.01) in TBARS level, compared to SHAM
group. Preconditioning with HBO therapy significantly decreased lipid peroxidation in plasma
in comparison to AKI (AKI+HBO-p<0.05; AKI+HBO+APO-p<0.01). There was no differ-
ence in TBARS level between AKI and AKI+APO groups.
Antioxidant enzymes. CAT activity dropped after AKI induction (p<0.001), while in
AKI+APO+HBO group its activity was significantly elevated in comparison to AKI (Fig 4A;
p<0.05). In SOD activity there was no significant difference among the groups (Fig 4B). In
AKI group GR activity was significantly lower compared to SHAM (p<0.05), while in compar-
ison to AKI, enzyme activity increased in HBO treated group (p<0.01; Fig 4C). GSH-Px activ-
ity significantly decreased in group with hyperbaric oxygen preconditioning (p<0.05), with no
differences among the other groups (Fig 4D).
Plasma KIM—1 levels
KIM-1 levels were significantly increased in AKI group compared to SHAM operated rats
(p<0.001). Remarkable decrease in KIM– 1 levels was noticed in groups with HBO precondi-
tioning (p<0.05) and HBO preconditioning with APO treatment (p<0.05), while in APO
group this decrease was not significant (p>0.05, Fig 5).
Histological findings
By comparison between the groups, significant differences in morphological alterations were
noticed. In SHAM operated rats, normal morphology of glomeruli, tubulointerstitium, and
Table 1. Systemic hemodynamic parameters.
SHAM (n = 9)§ AKI (n = 11) AKI+APO (n = 11)§ AKI+HBO (n = 14)§ AKI+APO+HBO (n = 7)
MAP
(mmHg)
133.11±14.90 102.18±15.28��� 91.45±18.46 97.71±20.06 102.29±18.06
HR
(beat/min)
435.33±17.77 366.91±92.27� 387.55±27.15 343.43±73.82 397.29±19.13
TVPR
(mmHg x min x kg/ml)
0.51±0.24 0.57±0.36 0.33±0.12# 0.36±0.08# 0.32±0.06#
CO
(ml/min/kg)
414.75±146.20 394.32±146.00 444.72±121.90 400.09±98.72 470.41±43.51
MAP-mean arterial pressure, HR-hearth rate, TVPR-Total peripheral vascular resistance, CO-cardiac output, n–number of animals.
§ for TVPR and CO, n = 8 (SHAM), n = 10 (AKI + APO), n = 12 (AKI+HBO),
�p<0.05,
���p<0.001 vs. SHAM group;
#p<0.05 vs. AKI group
https://doi.org/10.1371/journal.pone.0226974.t001
Hyperbaric oxygen preconditioning and NADPH oxidase inhibition in acute kidney injury
PLOS ONE | https://doi.org/10.1371/journal.pone.0226974 January 8, 2020 6 / 16
blood vessels were observed including rare kidney specimens with a few PAS positive casts in
the lumen of the tubules (Fig 6A). In animals with AKI significant morphological alterations
were present: tubular cells necrosis, dilatation of certain segments of the proximal and distal
tubules, mostly with loss of brush-border. The most notable changes were present in the cor-
tico-medullary zone, where the broad areas of tubular necrosis and a large number of PAS pos-
itive casts in the collecting ducts were observed (Fig 6B). In treated animals (AKI+APO, AKI
+HBO, AKI+APO+HBO) degrees of morphological changes were significantly lower com-
pared to AKI control. There were reduced tubular dilatation, tubular necrosis in the cortico-
medullary zone and PAS positive cast formation (Fig 6C, 6D and 6E). In addition, the histo-
pathological score (Fig 6F), as a sum of these changes was significantly higher in AKI group,
compared to SHAM control. In treated groups, this score was significantly lower in compari-
son to AKI (AKI vs. AKI+APO, p<0.001; AKI vs. AKI+HBO, p<0.01; AKI vs. AKI+APO
+HBO, p<0.01).
Fig 1. Renal hemodynamic parameters. RVR-renal vascular resistance, RBF-renal blood flow. ���p<0.001 vs. SHAM
group, #p<0.05, ###p<0.001 vs. AKI group.
https://doi.org/10.1371/journal.pone.0226974.g001
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Discussion
In this study has shown for the first time, that HBO preconditioning improves oxidative
defense in SHR, as well as, renal function and structure of hypertensive kidneys suffered post-
ischemic AKI. Further, we showed that NADPH oxidase has important role in development
and maintenance of AKI in hypertensive surrounding.
Hypertension is a condition with enhanced ROS generation [21]. Postischemic AKI is also
accompanied with increased plasma lipid peroxidation and oxidative stress [6, 7]. We showed
that both groups with HBO preconditioning, reduced lipid peroxidation. The therapeutic basis
behind HBO preconditioning is a significant increase in oxygen concentrations within differ-
ent tissues, which can increase production of ROS [22, 23]. Paradoxically, it is also an impor-
tant stimulus to upregulate antioxidant enzymes in response to a greater production of ROS
[22, 23]. In accordance, in present study, HBO preconditioning in combination with apocynin
Fig 2. Plasma creatinine (PCr), urea (PU) and phosphate (PPhos) concentration 24 h after reperfusion.
���p<0.001 vs. SHAM group, #p<0.05, ##p<0.01, ###p<0.001 vs. AKI group.
https://doi.org/10.1371/journal.pone.0226974.g002
Fig 3. Plasma TBARS levels 24 hours after reperfusion. ��p<0.01 vs. SHAM group, #p<0.05, ##p<0.01vs. AKI
group.
https://doi.org/10.1371/journal.pone.0226974.g003
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increased plasma catalase activity. Also, gluthatione reductase activity was increased in HBO
group. Kim et al. demonstrated that hyperbaric oxygen pretreatment induces catalase in the in
vivo heart and reduces infarct size in ischemic rat myocardium [24]. In those pathological con-
ditions catalase activity may be crucial for a protective effect against oxidative stress. In
Moreno et al. study, it is found that intensely stained CAT-immunoreactive cells (corre-
sponded to neurons) were resistant to ischemia reperfusion injury, whereas, weakly stained
cells were more susceptible to ischemic damage [25]. However, APO treatment solitary did
not reduce plasma lipid peroxidation nor affect erythrocytes antioxidant enzyme activities in
treated animals. Despite APO has traditionally used as NADPH oxidase inhibitor, to be effec-
tive it must be converted to an active dimer by myeloperoxidase [26]. Studies on HEK-293
cells showed that APO is not an NADPH oxidase inhibitor in myeloperoxidase free vascular
cells [27], which can partially explain lack of lipid peroxidation reduction. In contrary, it was
Fig 4. Erythrocytes catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and
glutathione reductase (GR) activity 24 hours after reperfusion. �p<0.05,���p<0.001 vs. SHAM, #p<0.05, ##p<0.01
vs. AKI.
https://doi.org/10.1371/journal.pone.0226974.g004
Fig 5. Plasma KIM—1 levels 24h after reperfusion. ��� p<0.001 vs. SHAM, # p<0.05 vs. AKI.
https://doi.org/10.1371/journal.pone.0226974.g005
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shown that APO could be an effective tool that inactivates NADPH oxidase in renal tissue
markedly reducing lipid peroxidation [28]. Activity of other antioxidant enzymes, SOD and
GSH-Px were unaffected by AKI or in our treated groups. Nevertheless, in hypertensive
patients, disturbances in glutathione related antioxidant defense are reported [29]. It has been
shown that glutathione peroxidase can be inactivated in the conditions of oxidative stress
Fig 6. Histopathology of the representative kidney samples collected in different experimental groups (PAS staining, x 20
magnification): Normal morphology of renal tissue including glomerular and tubulointerstitial compartments in the sham-
operated animals (A), proximal tubular dilatation (arrows), necrosis of tubular epithelial cells (�) and PAS-positive casts (��) in
the AKI group (B), moderately intensive tubular necrosis, reduced tubular dilatation and less number of PAS-positive casts in
AKI+APO (C), AKI+HBO (D), AKI+APO+HBO (E) groups and histopathological score as a sum of present morphological
changes (F). ���p<0.001 vs. SHAM, ##p<0.01, ###p<0.001 vs. AKI.
https://doi.org/10.1371/journal.pone.0226974.g006
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where superoxide radical may inhibit enzyme peroxide function and in hypertension patho-
genesis superoxide radical plays major role [29]. Also, SOD activity can be inactivated due to
enhanced production of oxidants, through modifications of the enzyme active site [30]. These
results are in a line with unaffected SOD activity in the present study [5].
ROS production have direct effects on vasoreactivity in renal vessels, with increased ROS
associated with enhanced renal RVR [6]. On the other hand NADPH oxidase is the major
source of ROS in many tissues, including the kidney, especially in AKI [31]. In the present
study, we used APO and confirmed that improved RBF, and decreased RVR, are in part,
induced by decreased oxidative stress. APO is experimentally used as an inhibitor of vascular
NADPH oxidases [32], but there is evidence proving that APO is not an inhibitor of vascular
NADPH oxidases, but is an antioxidant [27]. Indeed, Heumüller at al. showed that the inhibi-
tory action of apocynin for NADPH oxidases is restricted to myeloperoxidase—expressing leu-
kocytes and that the compound does not inhibit NADPH oxidases in myeloperoxidase—free
vascular cells [27]. The immune response to kidney damage during AKI is an important con-
tributor to reduced renal function and progression of kidney injury [33]. This response is com-
plex, involving numerous proinflammatory myeloperoxidase-expressing leukocytes which
employ diverse effector mechanisms inside the kidney, including increasing ROS [34–36]. Fur-
ther, Ivanov et al. previously explained that hypertension and postischemic acute kidney injury
are accompanied with elevated circulating levels of angiotensin II (Ang II). They had observa-
tion that NADPH oxidase activity can be stimulated by Ang II. Furthermore, in this study
authors demonstrated that in combine model of hypertension and postischemic AKI, kidney
oxidative injuries are strongly mediated by Ang II [6]. Taking all together, we can assume that
increased oxidative stress, besides increased level of Ang II itself, is very important factor
responsible for decreased RBF and increased RVR. Also, as accumulated renal leukocytes in
AKI are important source of ROS [33], it is reasonable to assume that ROS are, in part, respon-
sible for increased level of Ang II. It is also possible that APO, by its inhibitory action on
NADPH oxidases of myeloperoxsidase—expressing leukocytes is able to decrease the level of
Ang II, which will further decrease RVR and improve RBF. On the other hand, Schüter et al.,
showed that apocynin-induced vasodilatation is the result of Rho kinase inhibition [37], so
maybe there are some additional mechanisms of APO that are also involved in RBF improve-
ment and RVR decrease in AKI after APO treatment.
In the present study, we also demonstrated beneficial effect of HBO precondition on renal
hamodynamic. Our results are in accordance with Rubinstein at al. who claims that HBO
treatment can improve renal hemodynamic, due to the HBO induced renal vasodilatation
[38]. Klemetti et al. in their study indicate that short HBO treatment can be successfully used
for improving blood flow of healing tissues in rats [39]. Experimental evidence suggests benefi-
cial effects of HBO when used as a preconditioning stimulus in I/R injury. HBO seems to offer
a reservoir of oxygen that may last for a few hours and may have great importance in case of
sudden hypoxia or ischemia. Besides being carried through by blood, oxygen reaches to the
cellular level also by diffusion from the interstitial tissue in which it reaches high concentration
during HBO treatment. It improves endothelial function and decreases local inflammation
and edema [14]. Also, as increased ROS is associated with enhanced RVR, we can assume that
upregulated antioxidant enzyme activities [40,41] after HBO preconditioning may decreased
RVR by ROS scavenging that would further improve renal hemodynamic.
Considering obtained results of systemic hemodynamic after AKI induction, decreased
MAP and HR were noticed. These results are consistent with Bowmer study [42]. Namely,
these authors have brought together a high uremia influence on diminishing α1 adrenorecep-
tors sensitivity with the cause of both MAP and HR reduction after AKI [42]. This correlates
with high value of plasma urea in our study, as well. In the presented study in all treated groups
Hyperbaric oxygen preconditioning and NADPH oxidase inhibition in acute kidney injury
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TVPR was decreased, without changes in MAP and HR, after AKI induction. Rubinstein at al.
showed that in their model of ischemia/reperfusion renal injury, HBO did not affect MAP
[39]. However, TVPR decrease in HBO treated groups might be explained by decreased ROS
generation. Under normotensive conditions, blood pressure is closely regulated by several
endogenous vasodilators and constrictors and does not depend on vascular superoxide to a
significant extent. However, in hypertension, shear stress and several hormones induce stimu-
lus dependent ROS production in various vascular cell types, thereby inducing endothelial dys-
function and hypertension [43]. On the other hand, treatment with apocynin can reverse
vascular functional and structural changes in experimental hypertension and prevent or
reduce blood pressure elevation. Additional mechanism of action associated with apocynin
involves increased NO expression and activity [44].
The results of present study showed that ischemia reperfusion led to a significant increase
in creatinine, urea and phosphate levels with marked improvement in all treated groups. Dur-
ing renal damage in ischemia reperfusion injury, as a result of diminished glomerular filtration
rate, ability of the kidney to filter creatinine and nonprotein waste products is reduced [6].
Moreover, the levels of urea and uric acid are elevated, and hypophosphatemia frequently
occurs due to diminished expression of tubular sodium dependent phosphate cotransporter
[45]. Different studies indicate that APO could contribute in many ways to improve renal
function. By causing the inhibition of NADPH oxidase, APO expressed the ameliorative effect
to renal function which may be attributed to the protection against oxidative stress injury.
Besides this, APO prevents adenosine triphosphate depletion during ischemia that leads to
apoptosis and necrosis of tubular cells [46]. Also, by reducing leukocyte infiltration and pro-
duction of inflammatory cytokines, such as TNF-α, Il-1β and Il-6, it decreases an acute inflam-
matory response [47]. These results come in line with study of Altintas et al. who showed
improvement in kidney function after ischemia reperfusion injury in normotensive Wistar
albino rats [48]. Significant improvement can be seen in other experimental models, followed
by renal dysfunction, such as gentamicin-induced nephropathy [49]. HBO preconditioning
also improved renal function. Different studies suggest that HBO also has anti-inflammatory
effect by decreasing neutrophil infiltration and further tissue damage [50, 51]. Xiaoyhou He
et al. showed that HBO preconditioning protocol as we used in this study had beneficial effects
on renal function [52].
Since its discovery, KIM-1 has emerged as a sensitive and specific biomarker of kidney
injury in both rodent models and humans. KIM-1 may be released into the circulation after
kidney proximal tubule injury. First, it is released into the interstitium after tubular cell polar-
ity is lost. Further, increased transepithelial permeability leads to backleak of tubular contents
into the circulation with altered microvascular permeability as an important contributing fac-
tor [53]. Decreased KIM– 1 plasma levels in AKI+HBO and AKI+APO+HBO groups may
indicate minor degree of kidney tissue alterations which is in accordance with our previously
shown results and further histophatological findings.
Histopathological examination is the best way to analyze morphological changes in the kid-
ney tissue after AKI episode. Prominent morphological features of ischemic AKI include
effacement and loss of proximal tubule brush border, patchy loss of tubule cells, focal areas of
proximal tubular dilatation and distal tubule casts, and areas of necrosis are the most notable
changes in the ischemic kidney that can be seen by light microscopy [6]. In our study, morpho-
logical changes in the kidneys isolated from rats with induced ischemic AKI, exactly corre-
spond to the previous description.
Our results clearly indicate that APO, used to block NADPH oxidase in the early stages of
ischemic AKI in hypertension, has beneficial effects on renal morphological structure. Histo-
pathological examination confirmed less severe lesions of tubular epithelial cells, reduced
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tubular dilatation and less number of PAS-positive casts in treated animals. Altintas et al. [48]
showed a protective effect of APO on kidney morphology in Wistar Albino female rats with
ischemic AKI.
Numerous studies showed successful recovery potential of HBO therapy in kidney ische-
mia/reperfusion injuries [38, 52]. In this study, with or without apocynin, treatment with HBO
showed beneficial effects on renal morphological structure. Preconditioning with HBO ther-
apy decreased the number of PAS positive casts and the smaller fields of necrosis after ischemic
AKI. Rubinstein et al. showed that HBO therapy could have beneficial effects on a kidney
structure of male Sprague-Dawley rats 48h after ischemia [38]. Furthermore, He et al. in simi-
lar model on male Sprague-Dawley rats suggest that HBO preconditioning has a protective
effect on ischemia/reperfusion by reducing the free oxygen radical peroxidation of lipid mem-
branes, and increasing the activity of antioxidative enzymes [52].
These histological findings suggest that positive effect of treatment with HBO and apocynin
on morphological level are consistent with the improvement of both, renal artery hemody-
namic parameters, as well with better biochemical parameters of kidney function. Further-
more, oxidative stress parameters are in accordance with obtained histological findings
suggesting that improved antioxidant defense contributes to morphological protection.
Conclusion
In conclusion, we showed, for the first time that in experimental conditions, HBO precondi-
tioning as well as NADPH oxidase inhibition with or without HBO preconditioning, improve
kidney structure and function, increase renal blood flow, decrease renal vascular resistance
and increase antioxidative defense in SHR which suffer AKI. Also, these results suggest that it
is reasonable to assume that HBO preconditioning and NADPH oxidase inhibition potentially
may have beneficial effects, but further comprehensive experimental and clinical studies are
needed to confirm these promising results.
Supporting information
S1 Table. Full data set for systemic hemodynamic parameters in sham-operated rats
(SHAM), rats with induced postischemic AKI (AKI), animals with AKI and apocynin
treatment (AKI+APO), group with HBO preconditioning before AKI inducing (AKI
+HBO) and group with HBO preconditioning before and apocynin treatment after AKI
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